About

Subscribe

Contact

Psychedelic-Assisted Therapy

Psychedelic-assisted therapy is gaining momentum in clinical settings, with compounds like psilocybin, MDMA, and DMT being studied for their potential to treat PTSD, anxiety, depression, and addiction. This section explores trial data, therapeutic frameworks, FDA designations, and the evolving ethics around integration into psychiatric practice.

oral psilocin

Why Psilocin Instead of Psilocybin?

September 28, 2026

4-AcO-DMT and innate fear

How 4-AcO-DMT Alters Fear Circuits

September 24, 2026

What Is Psychedelic-Assisted Therapy

What Is Psychedelic-Assisted Therapy?

September 22, 2026

psilocybin for chemotherapy

Psilocybin Protects Nerves During Chemotherapy

September 19, 2026

Ayahuasca And Chronic Stress

Ayahuasca May Protect the Brain From Chronic Stress

September 10, 2026

Psilocybin Neurogenesis

Psilocybin Triggers Neurogenesis in Stressed Rats

September 8, 2026

MDMA Oxytocin Response

MDMA’s Oxytocin Effect Peaks Hours After Dosing

September 4, 2026

MDMA Mystical Experience

Does MDMA Need a Mystical Experience to Treat PTSD?

August 30, 2026

magnesium-ibogaine treatment

Ibogaine Benefits Persist at 12 Months in Veterans

August 27, 2026

Inhaled Mebufotenin For Postpartum Depression

5-MeO-DMT Shows Promise for Postpartum Depression

August 24, 2026

Back Next

Categories

Latest Articles

Join Our Email List

Sign up to receive the latest articles right in your inbox.